analytics_image
\
Vantage Market Research
Vantage Market Research

Reports - Automated Immunoassay Analyzers Market

iconHealthcare

Automated Immunoassay Analyzers Market

Automated Immunoassay Analyzers Market by Analyzer (Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers), by Application (Drug Discovery, Genomics, Proteomics, Bioanalysis), by Region (North America, Europe, Asia Pacific, Latin America) - Historic Data (2021 - 2023) & Forecast Period (2025 - 2035)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 22.23 Billion

Market Size By 2035

USD 95.25 Billion

CAGR (2025 - 2035)

14.15%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Analyzer, By Application, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

Market Synopsis:

The global Automated Immunoassay Analyzers Market is valued at USD 22.23 Billion in 2024 and is projected to reach a value of USD 95.25 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 14.15% between 2025 and 2035. The market for automated immunoassay analyzers is expected to develop due to the growing trend toward lab automation and the rising occurrence of infectious disorders. Due to incremental improvements to current items and expanded clinical applications, these products are gaining appeal. As a result of the increased use of automated immunoassay analyzers, demand and adoption rates will rise, propelling the market forward.

Automated Immunoassay Analyzers Market Size, 2024 To 2035 (USD Billion)

Recent automation and integration trends have resulted in the introduction of unique goods to the industry, hence propelling the market forward. They are increasingly being used for drug discovery by a variety of pharmaceutical and biotechnology companies. To obtain access to hospitals and laboratories, industry competitors are competing on the basis of immunoassay system features, throughput, and menu growth.




Increasing Incidence of Chronic and Infectious Diseases

Chronic diseases including diabetes, heart disease, and cancer are on the rise all across the world. Infectious diseases such as SARS-CoV2 (COVID-19), Dengue fever, Hepatitis B, C, HIV, Malaria, Tuberculosis, and others are spreading at an alarming rate. Immunoassay diagnosis has become a critical component of many disorders' diagnosis. Immunoassay technology is improving, resulting in faster results with improved efficacy, detection limits, sensitivity, and cost-effectiveness. The widespread use of fast tests and point-of-care testing for disease diagnosis, as well as drug and alcohol addiction, has propelled the worldwide immunoassay market to new heights.




Design Challenges

The technicians face lots of design challenges associated with the immunoassays such as misinterpretation of results. Also, the dearth of skilled professionals in the clinical diagnostics domain have posed challenges from several decades.

The Automated Immunoassay Analyzers market scope can be tabulated as below:

Market Segmentation:

Global Automated Immunoassay Analyzers market is segmented on the basis of Analyzers, into Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers. Based on Application into Drug Discovery, Geonomics, Others. Based on region, the Automated Immunoassay Analyzers market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.




North America to Continue Dominating the Automated Immunoassay Analyzers Market

During the projected period, North America is expected to dominate the worldwide Automated Immunoassay Analyzers market, followed by Europe. Increased adoption of technologically advanced Automated Immunoassay Analyzers products, high healthcare expenditures, advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, a large number of Automated Immunoassay Analyzers-based R&D projects, and the presence of a large number of leading Automated Immunoassay Analyzers manufacturers in the region, as well as increased demand for genotyping products from pharmaceutical companies and rising government investments, by government bodies, are responsible for the large share of the North American Automated Immunoassay Analyzers market.

Key Players:

Key participants operating in the Automated Immunoassay Analyzers market is: Abbott Diagnostics (US)

The Automated Immunoassay Analyzers market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Analyzer

  • Biochemistry Analyzers
  • Immuno-based Analyzers (35.6%)
  • Hematology Analyzers

By Application

  • Drug Discovery (15.7%)
  • Genomics
  • Proteomics
  • Bioanalysis
  • Analytical Chemistry
  • Clinical Diagnostics

By Region

  • North America (U.S., Canada, Mexico) (38.9%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Abbott Diagnostics (US)
  • Biokit (Spain)
  • Biomerieux (France)
  • Luminex Corporation (US)
  • Roche Diagnostics (Switzerland)
  • and Siemens Healthcare (Germany).
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

Related Reports

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Automated Immunoassay Analyzers Market Trends, Growth & Innovations (2025–2035)